Key result
New Zealand cardiovascular research persistently fails to report and analyze gender-specific data and disparities.
Why the study?
Cardiovascular disease is a leading cause of mortality among women in Aotearoa New Zealand, yet significant gaps persist in understanding how heart disease uniquely affects women and in adequately examining, reporting, and analysing gender-specific research data.
Systematic Review
Closing the gender data gap through mandatory sex-disaggregated reporting and adequate sample sizing is essential to address underdiagnosis, undertreatment, and health inequities for women with cardiovascular disease in Aotearoa New Zealand.
Answers are grounded in this paper and cite their sources.
Caution is warranted when applying regional evidence to women with CVD; confirms global under-representation and highlights the need for mandatory sex-disaggregated trial reporting.
Cardiovascular disease remains a leading cause of mortality among women in Aotearoa New Zealand, yet significant gaps persist in our understanding of how heart disease uniquely affects women. A systematic review of women’s cardiovascular health in Aotearoa New Zealand revealed a concerning pattern: not a lack of cardiovascular research, but a persistent failure to adequately examine, report and analyse gender-specific data. Most studies provided minimal gender analysis beyond demographic representation, and many documented that women receive less treatment than men without exploring why these disparities exist or their clinical implications. This “gender data gap” mirrors international patterns of women’s under-representation in cardiovascular research and widespread underdiagnosis and undertreatment. The consequences are profound: clinical guidelines fail to address women’s cardiovascular presentations, systemic barriers remain invisible and healthcare providers lack the evidence base for gender-responsive care. For Māori and Pacific women, inadequate gender analysis compounds intersecting inequities. We present actionable recommendations for researchers, funders and publishers, including appropriate sample sizing for equal explanatory power, mandatory sex-disaggregated reporting, culturally responsive research practices and interrogation of observed gender differences. Closing the gender data gap is essential for health equity and justice for all Aotearoa New Zealand women.
No takes yet. Share an insight, caveat, or question.
Bussey et al. (2026) conducted a systematic review in Cardiovascular disease in women. Gender-specific data analysis and reporting vs. Minimal gender analysis or male participants was evaluated on Adequacy of examination, reporting, and analysis of gender-specific cardiovascular data. Cardiovascular research in Aotearoa New Zealand persistently fails to adequately examine, report, and analyze gender-specific data, leaving treatment disparities in women largely unexplored.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: